showed that PD1 − CD4+ T cells had higher TNFα and higher CCR4 expression, while their PD1+ CD4+ T cells had higher interferon-γ and lower CCR4 expression in non-responder cases to ICI in urothelial and renal cell carcinoma (52). This evidence concerns the gene PDCD1 and renal cell carcinoma.